Evidence map›Paper›PMID 32232838›Full record

ArticleJournal of the American Geriatrics Society2020

Clinician Perspectives on Overscreening for Cancer in Older Adults With Limited Life Expectancy.

Nancy L Schoenborn, Jacqueline Massare, Reuben Park, Craig E Pollack, Youngjee Choi, Cynthia M Boyd

Abstract read
In one paragraph

Article in Journal of the American Geriatrics Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Competing Causes of Death in Older Adults with Thyroid Cancer.Thyroid : official journal of the American Thyroid Association · 2021
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nancy L SchoenbornDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jacqueline MassareDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Reuben ParkThe Johns Hopkins University, Baltimore, Maryland, USA.
Craig E PollackDepartment of Healthy Policy and Management, The Johns Hopkins University School of Public Health, Baltimore, Maryland, USA.
Youngjee ChoiDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Cynthia M BoydDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI WILLIAM George NELSON · 1985 to 2026
$208.6M
Patient-Centered Care for Older Adults with Multiple Chronic Conditions: Research and Mentoring ProgramK24AG056578 · NIA · JOHNS HOPKINS UNIVERSITY · PI BOYD, CYNTHIA MELINDA · 2017 to 2021
$1.1M
Improving cancer screening in older adults with limited life expectancyK76AG059984 · NIA · JOHNS HOPKINS UNIVERSITY · PI SCHOENBORN, NANCY · 2018 to 2021
$972k
NCI NIH HHS P30 CA006973NIA NIH HHS K24 AG056578NIA NIH HHS K24AG056578NIA NIH HHS K76 AG059984NIA NIH HHS K76AG059984
6 · The paper itself

Abstract

BACKGROUND/

objectivesGuidelines recommend against routine screening for breast, colorectal, and prostate cancers in older adults with less than 10 years of life expectancy. However, clinicians often continue to recommend cancer screening for these patients. We examined primary care clinicians' perspectives regarding overscreening, as defined by limited life expectancy.

designSemistructured, in-depth individual interviews.

settingTwenty-one academic and nonacademic primary care clinics in Maryland.

participantsThirty primary care clinicians from internal medicine, family medicine, medicine/pediatrics, and geriatric medicine. MEASUREMENTS: Interviews explored whether the clinicians believed that overscreening for breast, colorectal, or prostate cancers existed in older adults and their views on using life expectancy to decide on stopping routine screening. Audio recordings of the interviews were transcribed verbatim. Two investigators independently coded all transcripts using qualitative content analysis.

resultsMost clinicians were physicians (24/30) and women (16/30). Content analysis generated three major themes. (1) Many, but not all, clinicians perceived overscreening in older adults as a problem. (2) There was controversy around using limited life expectancy to define overscreening due to concerns that the guidelines did not capture potential nonmortality benefits of screening; that population-based screening data could not be easily applied to individuals; that this approach failed to account for patient choice; and that life expectancy predictions were inaccurate. (3) Some clinicians worried that using life expectancy to define overscreening may inadvertently introduce bias and lead to unintended harms.

conclusionsSeveral clinicians disagreed with guideline frameworks of using limited life expectancy to guide cancer screening cessation. Some disagreement stems from inadequate knowledge about the benefits and harms of cancer screening and indicates a need for education or decision support. Other reasons for disagreement highlight the need to refine the current recommended cancer screening approaches and identify strategies to avoid unintended consequences, such as introducing bias or exacerbating existing disparities. J Am Geriatr Soc 68:1462-1468, 2020.

Indexed as

Decision MakingEarly Detection of CancerUnnecessary ProceduresBreast NeoplasmsColorectal NeoplasmsFemaleGeriatricsHumansInterviews as TopicLife ExpectancyMaleMarylandMiddle AgedPhysicians, Primary CareProstatic NeoplasmsQualitative Researchcancer screeningclinician perspectivelife expectancy

Identifiers

PMID32232838
PMCPMC7884865

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.